Retinopathy of prematurity: an epidemic in the making

Graham E Quinn1, Clare Gilbert, Brian A Darlow

  • 1Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA. quinn@email.chop.edu

Chinese Medical Journal
|November 2, 2010
PubMed

Insights

Retinopathy of prematurity (ROP) is a growing threat to premature infants

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is an emerging threat to infant vision, particularly in regions with increasing survival rates of premature infants.
  • The incidence and prevalence of ROP are influenced by advancements in neonatal care, leading to a larger population of at-risk infants.

Purpose of the Study:

  • To comprehensively review the etiology, incidence, and current prevention and treatment strategies for severe retinopathy of prematurity (ROP).
  • To highlight the global variations in ROP risk identification and management approaches.

Main Methods:

  • A systematic literature review of Medline and PubMed databases using the search term "retinopathy of prematurity and premature birth".
  • Discussion of historical perspectives, classification, and treatment modalities for ROP in premature infants.

Main Results:

  • Peripheral retinal ablation is effective in preventing blindness in severe ROP cases.
  • Preventive measures include improved antenatal/obstetric care, antenatal corticosteroids, optimized neonatal care, and careful oxygen management.
  • Sepsis is a risk factor for severe ROP; genetic factors and telemedicine may aid detection.
  • Anti-VEGF therapy shows potential but requires cautious use due to unknown long-term effects.

Conclusions:

  • ROP is increasingly prevalent due to improved neonatal services, posing a significant risk to premature infants' vision.
  • Prioritizing ROP prevention strategies, including reducing preterm birth, enhancing neonatal care, and expanding ophthalmological services, is crucial to combat ROP-related blindness.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...